Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 5/2009

01-10-2009 | Original Article

Can hybrid FDG-PET/CT detect subclinical lymph node metastasis of esophageal cancer appropriately and contribute to radiation treatment planning? A comparison of image-based and pathological findings

Authors: Shinichi Shimizu, Masao Hosokawa, Kazuo Itoh, Masahiro Fujita, Hiroaki Takahashi, Hiroki Shirato

Published in: International Journal of Clinical Oncology | Issue 5/2009

Login to get access
Metadata
Title
Can hybrid FDG-PET/CT detect subclinical lymph node metastasis of esophageal cancer appropriately and contribute to radiation treatment planning? A comparison of image-based and pathological findings
Authors
Shinichi Shimizu
Masao Hosokawa
Kazuo Itoh
Masahiro Fujita
Hiroaki Takahashi
Hiroki Shirato
Publication date
01-10-2009
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 5/2009
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-009-0893-4

Other articles of this Issue 5/2009

International Journal of Clinical Oncology 5/2009 Go to the issue

Case Report

Meningeal dissemination from an ovarian carcinoma with effective response to intrathecal chemotherapy

Review Article

Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management

Review Article

Ovarian cancer in endometriosis: epidemiology, natural history, and clinical diagnosis

Original Article

High-frequency 30-MHz sonography in preoperative assessment of tumor thickness of primary melanoma: usefulness in determination of surgical margin and indication for sentinel lymph node biopsy

Review Article

Management of patients with pregnancy-associated gastric cancer in Japan: a mini-review

Original Article

Cardiac safety of trastuzumab as adjuvant treatment for Japanese patients with early breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits